Ounalli Asma, Moumni Imen, Mechaal Amal, Chakroun Aya, Barmat Mbarka, Rhim Rim El Elj, Menif Samia, Safra Ines
Laboratory of Molecular and Cellular Hematology, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Faculty of Mathematics, Physics and Natural Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Front Oncol. 2023 Oct 16;13:1272876. doi: 10.3389/fonc.2023.1272876. eCollection 2023.
Genetic variations in gene are known to be important in chronic lymphocytic leukemia (CLL) and may cause its inactivation which is associated with an aggressive form of the disease. Single nucleotide polymorphism (rs1042522:G>C) in gene at codon 72 encodes for arginine (Arg) or proline (Pro) variant which results in amino acid substitution affecting the apoptotic potential of protein. The aim of this study was to assess the correlation between codon 72 polymorphism and risk susceptibility as well as severity of CLL among Tunisian patients.
A case-control study was conducted in Tunisia from February 2019 to November 2021, 160 CLL patients and 160 healthy volunteers matched in age and gender were involved. DNA was extracted from peripheral blood mononuclear cells and the rs1042522 was analyzed using PCR-RFLP.
Pro variant was associated with higher susceptibility to CLL than Arg variant (p= 0.023). A significant association was found between Pro variant and prognostic classification of Binet stage C (p= 0.001), low hemoglobin level (p= 0.003) and low platelet count (p= 0.016).
We suggest that Pro variant may increase the risk of developing CLL in our population and could be associated with the severity of the disease.
已知该基因的遗传变异在慢性淋巴细胞白血病(CLL)中具有重要意义,可能导致其失活,这与该疾病的侵袭性形式相关。该基因第72密码子处的单核苷酸多态性(rs1042522:G>C)编码精氨酸(Arg)或脯氨酸(Pro)变体,导致氨基酸替换,影响该蛋白的凋亡潜能。本研究的目的是评估突尼斯患者中该基因第72密码子多态性与CLL风险易感性以及严重程度之间的相关性。
2019年2月至2021年11月在突尼斯进行了一项病例对照研究,纳入了160例CLL患者和160名年龄和性别匹配的健康志愿者。从外周血单个核细胞中提取DNA,并使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析rs1042522。
与Arg变体相比,Pro变体与CLL的易感性更高相关(p = 0.023)。发现Pro变体与Binet分期C的预后分类(p = 0.001)、低血红蛋白水平(p = 0.003)和低血小板计数(p = 0.016)之间存在显著关联。
我们认为Pro变体可能增加我们人群中发生CLL的风险,并可能与疾病的严重程度相关。